Canada markets close in 4 hours 46 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
153.78+2.56 (+1.69%)
As of 11:14AM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts21212222
Avg. Estimate-1.11-1.06-3.63-1.84
Low Estimate-1.57-1.69-5.56-4.38
High Estimate-0.36-0.31-1.072.31
Year Ago EPS-2.211.15-3.52-3.63
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts23222827
Avg. Estimate444.96M459.42M1.87B2.29B
Low Estimate415M441M1.73B1.48B
High Estimate489M495.5M2B2.97B
Year Ago Sales318.75M750.53M1.83B1.87B
Sales Growth (year/est)39.60%-38.80%2.00%23.00%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-1.37-1.34-1.32-1.18
EPS Actual-2.211.15-1.1-0.52
Difference-0.842.490.220.66
Surprise %-61.30%185.80%16.70%55.90%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.11-1.06-3.63-1.84
7 Days Ago-1.04-1.1-4.11-1.76
30 Days Ago-1.04-1.1-4.18-1.76
60 Days Ago-1.03-1.1-4.18-1.77
90 Days Ago-1.21-1.32-4.2-1.04
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days65114
Up Last 30 Days10112210
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days7838
Growth EstimatesALNYIndustrySector(s)S&P 500
Current Qtr.49.80%N/AN/AN/A
Next Qtr.-192.20%N/AN/AN/A
Current Year-3.10%N/AN/AN/A
Next Year49.30%N/AN/AN/A
Next 5 Years (per annum)-177.50%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A